Ketamine Therapy Blog — Mental Health Insights & Treatment Guides
Expert insights on ketamine therapy, depression, anxiety, PTSD, and mental health treatment — updated regularly by the Isha Health clinical team.
Ketamine Therapy in NYC: At-Home vs. In-Clinic IV Safety
Returning home alone after an IV ketamine session via subway carries real safety risks. Compare in-clinic infusions with at-home ketamine therapy for New Yorkers.
Ketamine for Bipolar Depression: What a Landmark NIMH Trial Found
A 2010 NIMH trial tested ketamine as an add-on treatment for bipolar depression. Here's what Diazgranados et al.
Esketamine vs. Racemic Ketamine: What's the Difference and What Does the Evidence Show?
Esketamine (Spravato) and racemic ketamine are related but distinct. Here's a comparison of the evidence, mechanisms, and practical differences between these.
How AI Scribes Restore Presence in Mental Health
Discover how AI scribes like Moco and DeepScribe are reducing burnout and restoring human connection in mental health care. Read the full comparison.
Ketamine-Assisted Psychotherapy: Outcomes from Three Large Clinical Practices
A 2019 study examined outcomes from three large ketamine-assisted psychotherapy practices. See what the data showed about real-world KAP effectiveness.
Who Owns Your Mental Health Data?
You tell your therapist things you've never told anyone. But do you know who owns that data? What HIPAA covers, what it doesn't, and how to protect yourself.
Ketamine and Fear Memory Reconsolidation: A New Angle on PTSD Treatment
NMDA receptors play a key role in fear memory reconsolidation. Here's how ketamine's mechanism may help disrupt traumatic memories and what this means for PTSD.
Hidden Costs of Bad Behavioral Health Docs
Bad clinical documentation doesn't just cost your therapist money — it costs you in denied claims, gaps in care, and treatment that doesn't build on itself.
Ketamine for OCD: Emerging Evidence from a Proof-of-Concept Crossover Trial
A 2013 proof-of-concept trial tested ketamine in obsessive-compulsive disorder. Here's what Rodriguez et al.
Why Your Therapy Notes Matter More Than You Think
Therapy insights fade fast. See how AI documentation closes the gap between what happens in session and what you remember — and why it matters for KAP.
Ketamine for Social Anxiety Disorder: Results from a Randomized Crossover Trial
A 2018 placebo-controlled crossover trial tested ketamine for social anxiety disorder. Here's what the results showed and what they mean for patients.
Ketamine for Generalized Anxiety Disorder: Dose-Related Effects in Treatment-Refractory Patients
A 2017 dose-ranging study found that ketamine may reduce anxiety symptoms in patients with treatment-refractory anxiety disorders. Here's what the evidence shows.
Page 6 of 19
Get new articles in your inbox
Research updates and clinical insights on ketamine therapy — no spam.